Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 484, pseudogene (RN7SL484P)

Target
RN7SL484P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RNA, 7SL, cytoplasmic 484, pseudogene (RN7SL484P) is a **pseudogene** of the 7SL RNA family. The 7SL RNA is the RNA component of the signal recognition particle (SRP), which is essential for targeting newly synthesized proteins to the endoplasmic reticulum in eukaryotes[1][3][5]. However, RN7SL484P itself is classified as a *pseudogene*, meaning it is a non-functional copy of a gene that generally does not produce a functional product, and does not participate in SRP activity[4]. Pseudogenes like RN7SL484P may sometimes act as regulatory non-coding RNAs, influencing expression of related genes through sequence similarity, but direct functional or disease relevance for RN7SL484P is not established in the current scientific literature[2][4]. This pseudogene is not recognized as a therapeutic target, biomarker, or druggable entity. **Notes:** - Is_incorrect is marked as true because this entity is a pseudogene, not an active molecular target such as a receptor, enzyme, or transporter, and lacks established biological activity or direct relevance as a therapeutic target[4]. - Most structured databases and primary resources only confirm RN7SL484P as a transcriptionally silent non-coding pseudogene; detailed functional data or disease associations are lacking[4]. - For related entries, 7SL RNA (RN7SL1) is the functional molecule in the SRP complex, not RN7SL484P[5].

Other names
RN7SL484P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 484, pseudogene (RN7SL484P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 484, pseudogene (RN7SL484P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call